Get started
Work

Supplementary Methods from A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors

Year: 2023
Type: supplementary-materials
Abstract: PDF file, 37K, Human PBMCs Sample Preparation, Western Blot assay for Hsp90 Client Proteins, Luminex Assay for Hsp90 Client Proteins.
DOI: 10.1158/1078-0432.22446650.v1
Authors: Komal Jhaveri, Kathy Miller, Lee Rosen, Bryan Schneider, Linnea Chap, Alison Hannah, Ziyang Zhong, Weining Ma, Clifford Hudis, Shanu Modi
Language: English
Open Access status: gold
OpenAlex ID: W4361903540
Cites:
Cited by:
Related to: 10